𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1138 PRETREATMENT VIRAL GENETIC FACTORS IMPROVE IL28B PREDICTIONS OF VIROLOGIC RESPONSE TO STANDARD THERAPY IN HEPATITIS C VIRUS 1B INFECTED PATIENTS

✍ Scribed by Saludes, V.; Bascuàana, E.; Ardévol, M.; Gonzalez, V.; Planas, R.; Morillas, R.; Sala, M.; Ausina, V.; Martrò, E.

Book ID
123045435
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
62 KB
Volume
56
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors of virological non-re
Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load
✍ Norio Akuta; Fumitaka Suzuki; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract Patients with high viral load (≥1.0 × 10^5^ IU/ml) of hepatitis C virus (HCV) genotype 1b do not achieve high sustained virological response rates to interferon (IFN)/ribavirin combination therapy. Previous studies suggested that pretreatment amino acid (aa) substitution patterns in the

Factors predictive of response to interf
Factors predictive of response to interferon-α therapy in hepatitis C virus type 1b infection
✍ Byung-Il Yeh; Kwang-Hyub Han; Hyean-Woo Lee; Joon Hyung Sohn; Wang-Shick Ryu; Do 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

## Abstract Interferon‐α (IFN‐α) has been used to treat hepatitis C Virus (HCV)‐induced infection but has been effective in only about half of all patients. It is suggested that the different responses to IFN‐α treatment in HCV infection may be influenced by HCV genotypes, HCV RNA titer at the begi

Prediction of response to peginterferon-
Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b
✍ Yoshimasa Hashimoto; Hidenori Ochi; Hiromi Abe; Yasufumi Hayashida; Masataka Tsu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v